BIOS Health Ltd
Hybrid
Some members of the team work remotely, while others are co-located in one or more offices.
👥11-50
📍Cambridge
BIOS Health Ltd
About BIOS Health Ltd
BIOS is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
BIOS Health Ltd news and updates
BIOS Health Ltd. is developing AI-controlled closed-loop neuromodulation system for chronic cardiac conditions
BIOS Health has secured $1.4 million of new funding to extend its Canadian neuro-cardiology collaboration with Mila, McGill University and the Université de Montréal to develop an AI-controlled closed-loop neuromodulation system for chronic cardiac conditions.
Jan 1, 2022 | cambridgeindependent.co.ukBIOS Health Ltd. received financing of $1.4M in funding on Jul 13th 22'.
In early 2021, SPARC awarded BIOS a $1.4 million grant to efficiently explore neuromodulation parameters to help accelerate the development of neural treatments for chronic disease, using BIOS’ unique neural biomarker technology.
Jan 1, 2022 | bios.healthBIOS Health Ltd. received financing of $4.5M in seed round on Dec 4th 18'.
BIOS announced today that it has raised a $4.5M USD seed round which includes investment from Montréal-based Real Ventures.
Dec 4, 2018 | montrealinternational.com